Table 2.
Structural Class | PFAS | CFC | Conc (μM) | Mort 24 | Mort 120 | EPR | LPR | LSR | n (LPR/LSR) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | E | R | Light | Dark | AUC | Peak | Controls | Treated | |||||||
Carboxylic acids | PFBA | 3 | 1.17 | HYPER | 31 | 32 | |||||||||
PFPeA | 4 | 0.95 | HYPO | 31 | 29 | ||||||||||
PFHxA | 5 | 0.80 | HYPER | 30 | 32 | ||||||||||
PFHpA | 6 | 0.69 | 30 | 32 | |||||||||||
PFOA | 7 | 0.60 | 31/32 | 32 | |||||||||||
PFNA | 8 | 0.54 | HYPO | 31/32 | 32 | ||||||||||
PFDA | 19 | 0.49 | 31 | 30/32 | |||||||||||
PFUdA | 10 | 0.44 | 31 | 30 | |||||||||||
PFDoA | 11 | 0.41 | HYPER | 32 | 31 | ||||||||||
PFTrDA | 12 | 0.38 | 32 | 31 | |||||||||||
PFTeDA | 13 | 0.35 | HYPO | 32 | 31 | ||||||||||
PFHxDA | 15 | 0.31 | 32 | 29 | |||||||||||
PFODA | 17 | 0.27 | HYPER | 32 | 32 | ||||||||||
Fluorotelomer carboxylic acids | FPrPA | 3 | 1.03 | 28 | 30 | ||||||||||
FPePA | 5 | 0.73 | 31 | 29 | |||||||||||
FHpPA | 7 | 0.57 | HYPO | 31 | 30 | ||||||||||
Unsaturated fluorotelomer carboxylic acids | FHUEA | 6 | 0.70 | 30 | 29 | ||||||||||
FOUEA | 8 | 0.55 | 30 | 29 | |||||||||||
Ether/polyether carboxylic acids | HFPO-DA | 3,2 | 0.76 | HYPO | 32 | 31 | |||||||||
NaDONA | 1,3,2 | 0.62 | 32 | 30 | |||||||||||
Sulfonic acids | PFPrS | 3 | 0.92 | HYPO | 28 | 29 | |||||||||
PFBS | 4 | 0.74 | HYPER | 27 | 28 | ||||||||||
PFPeS | 5 | 0.67 | HYPER | 27 | 27 | ||||||||||
PFHxS | 6 | 0.57 | 28 | 27 | |||||||||||
PFHpS | 7 | 0.53 | HYPO | 28 | 26 | ||||||||||
PFOS | 8 | 0.46 | HYPO | 29 | 29 | ||||||||||
8-Cl PFOS | 8 | 0.46 | HYPO | 30 | 29 | ||||||||||
PFNS | 9 | 0.44 | 24 | 26 | |||||||||||
PFDS | 10 | 0.40 | 30 | 31 | |||||||||||
PFDoS | 11 | 0.35 | 31 | 30 | |||||||||||
Sulfonic acids (cyclic) | PFECHS | 8 | 0.50 | HYPO | 29 | 31 | |||||||||
Fluorotelomer sulfonic acids | 4:2 FTS | 4 | 0.71 | 31 | 30 | ||||||||||
6:2 FTS | 6 | 0.56 | 31 | 32 | |||||||||||
8:2 FTS | 8 | 0.45 | 28 | 29 | |||||||||||
10:2 FTS | 10 | 0.38 | 31 | 30 | |||||||||||
Sulfonamides | N-Methyl FOSA | 8 | 0.49 | 30 | 31 | ||||||||||
N-Ethyl FOSA | 8 | 0.47 | 30 | 30 | |||||||||||
Sulfonamidoacetic acids | FOSAA | 8 | 0.45 | 27 | 28 | ||||||||||
N-Methyl FOSAA | 8 | 0.44 | 27 | 27 | |||||||||||
N-Ethyl FOSAA | 8 | 0.43 | 27 | 25 | |||||||||||
Chlorinated ether sulfonic acids | 9-Cl PF3ONS | 6,2 | 0.44 | 27 | 27 | ||||||||||
11-Cl PF3OUdS | 8,2 | 0.37 | 29 | 32 | |||||||||||
Phosphonic acids | PFHxPA | 6 | 0.62 | HYPO | 32 | 30 | |||||||||
Cl PFHxPA * | 6 | 0.40 | 28 | 28 | |||||||||||
PFOPA | 8 | 0.50 | 30 | 31 | |||||||||||
Cl PFOPA | 8 | 0.48 | HYPER | 25 | 25 | ||||||||||
PFDPA | 10 | 0.42 | 32 | 31 | |||||||||||
Phosphate ethers (mono-/di-substituted) | 6:2 PAP | 6 | 0.51 | 29 | 28 | ||||||||||
8:2 PAP | 8 | 0.43 | 29 | 23 | |||||||||||
SAMPAP | 8 | 0.36 | 30 | 30 | |||||||||||
6:2 DiPAP | 6,6 | 0.31 | 28 | 29 | |||||||||||
8:2 DiPAP | 8,8 | 0.25 | HYPER | 28 | 31 | ||||||||||
DiSAMPAP | 8,8 | 0.20 | HYPER | 28 | 26 | ||||||||||
Phosphinic acids | 6:6 PFPiA | 6,6 | 0.35 | HYPO | 27 | 25 | |||||||||
8:8 PFPiA | 8,8 | 0.27 | 27 | 26 | |||||||||||
Zwitterions | N-CMAMP | 6 | 0.44 | 24 | 24 | ||||||||||
N-AP-FHxSA | 6 | 0.52 | 26 | 28 | |||||||||||
N-TAMP-FHxSA | 6 | 0.50 | 26 | 31 | |||||||||||
Mixtures | PFC-MXA | - | 0.27** | 28 | 27 | ||||||||||
Mixture B | - | 0.023** | HYPER | 28 | 25 |
CFC = Continuously fluorinated carbons; Conc = Concentration; Mort = Mortality (at 24 and 120 hpf, respectively); EPR = Embryonic Photomotor Response: B = Background, E = Excitatory, R = Refractory period; LPR = Larval Photomotor Response (light and dark periods, respectively); LSR = Larval Startle Response: AUC = Area Under the Curve analysis, Peak = peak analysis; n (LPR/LSR) = Sample sizes of the control and treated groups; Results: HYPER = hyperactive (yellow), HYPO = hypoactive (blue) compared to controls. Grey coloring indicates no significant effect.
Tested at half the target concentration due to dilution error (0.4 μM).
Concentration describes ∑PFAS in mixture.